Cell and Gene Therapy, Cell Therapy, Leadership
June 25, 2024
Cell and Gene Therapy, Leadership
March 07, 2024
Governor Healey Highlights Life Sciences Investments from Mass Leads Act in Worcester and Hopkinton
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing
December 11, 2023
RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel)
Cell and Gene Therapy, Leadership
December 07, 2023
Ian McCubbin receives Peter Dunnill award at bioProcessUK
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing
November 28, 2023
RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration
Cell and Gene Therapy, Leadership
October 04, 2023
RoslinCT to Present at 2023 Cell & Gene Meeting on the Mesa
Cell and Gene Therapy, Leadership
October 03, 2023
RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
Cell and Gene Therapy, SAB
August 17, 2023
RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board
Cell Therapy, cGMP Manufacturing
June 05, 2023